Bax inhibitor peptide V5

579492-81-2

C27H50N6O6S

DMSO : >= 30 mg/mL (51.13 mM)

Apoptosis; Apoptosis

Bax inhibitor peptide V5 is a Bax-mediated apoptosis inhibitor, used for cancer treatment. In Vitro: Bax inhibitor peptide V5 (0-50 uM) reduces cell death in STF-cMyc cells but not in SW620 or NCI-H23 cells. BIPV5 does not result in any significant effect on cell cycle arrest at the G2/M phase^[1]. V5 treatment upregulates expression of anti-apoptotic proteins Bcl-2 and XIAP by more than 3- and 11-fold and downregulates expression of apoptosis-inducing proteins Bax, Bad, and nuclear factor-kappaB-p65 by 10, 30, and nearly 50%, respectively^[2]. In Vivo: V5 (100 uM) significantly improves islet function following isolation and improves islet graft function following transplantation in mice model^[2].